Status:

UNKNOWN

Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical Trial

Lead Sponsor:

Cairo University

Conditions:

Oral Lichen Planus

Eligibility:

All Genders

15-70 years

Phase:

PHASE1

Brief Summary

The aim of the present investigation is to assess the clinical therapeutic effect of topical use of Coenzyme Q10 versus topical corticosteroid in management of symptomatic oral lichen planus and deter...

Detailed Description

Oral lichen planus (OLP) is a relatively common chronic inflammatory mucocutaneous autoimmune disease that primarily affects the skin and mucosal surfaces including the oral cavity with a variety of c...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients free from any systemic disease according to the detailed questionnaire of the modified Cornell Medical Index 34.
  • Patients not receiving any medication either topical or systemic that could cause lichenoid reaction during the 3 months before the study.
  • Patients diagnosed by a dermatologist and oral medicine specialist as suffering from OLP.
  • Patients clinically and histopathologically diagnosed as suffering from OLP according to World Health Organization's (WHO's) clinic-pathological diagnostic criteria for LP35.
  • Patients who agree for the biopsy in undiagnosed cases.
  • Patients who are willing to participate in this study (will give informed consent) and have the ability to complete the study.
  • Exclusion criteria:
  • (1) Patients taking systemic drugs such as systemic steroid, other immunosuppressive therapy for at least 8 weeks prior to the study.
  • (2) Patients treated with any oral topical medications for at least four weeks prior to the study.
  • (3) Patients with suspected restoration-related reaction. (4) Pregnant and lactating mothers.

Exclusion

    Key Trial Info

    Start Date :

    October 1 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    November 1 2021

    Estimated Enrollment :

    34 Patients enrolled

    Trial Details

    Trial ID

    NCT04091698

    Start Date

    October 1 2019

    End Date

    November 1 2021

    Last Update

    September 17 2019

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.